Completion of disposal

RNS Number : 8371L
Dechra Pharmaceuticals PLC
15 August 2013
 

 

Dechra Pharmaceuticals PLC

("Dechra" or the "Company")

 

Completion of Disposal

 

 

16 August 2013

 

 

The Board of Dechra is pleased to announce that the disposal of the Services Segment announced on 10 July 2013 has now completed.  

 

 

Enquiries:

Ian Page, Chief Executive Officer

Fiona Tooley, Director

Dechra Pharmaceuticals PLC

TooleyStreet Communications

Telephone: + 44 (0) 1606 814730

Telephone: +44 (0) 121 309 0099

www.dechra.com

Mobile: +44 (0) 778 570 3523 (FT)


Ticker: Full Listing (Pharmaceuticals): DPH

 

 

About Dechra

Dechra is an international veterinary pharmaceutical business.  Its expertise is in the development, manufacturing, sales and marketing of high quality products exclusively for veterinarians worldwide. Dechra's business is unique as the majority of its products are used to treat medical conditions for which there is no other effective solution or have a clinical or dosing advantage over competitor products.  For more information please visit: www.dechra.com

 

Trademarks

Dechra and the Dechra "D" logo are registered trademarks of Dechra Pharmaceuticals PLC.

 

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
STRGGUPWRUPWGMA
UK 100

Latest directors dealings